Download - WHOCC
Download - WHOCC
Download - WHOCC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
QC05C<br />
QC05CA<br />
QC05CX<br />
CAPILLARY STABILIZING AGENTS<br />
Bioflavonoids<br />
Other capillary stabilizing agents<br />
QC07<br />
BETA BLOCKING AGENTS<br />
Agents blocking the beta receptors or with combined alpha- and beta blocking<br />
effect should be assigned to this group.<br />
Combinations of beta blocking agents and other active ingredients are classified<br />
in the following groups:<br />
QC07A - Beta blocking agents<br />
QC07B - Beta blocking agents and thiazides<br />
QC07C - Beta blocking agents and other diuretics<br />
QC07D - Beta blocking agents, thiazides and other diuretics<br />
QC07E - Beta blocking agents and vasodilators<br />
QC07F - Beta blocking agents and other anti-hypertensives<br />
QC07A<br />
BETA BLOCKING AGENTS<br />
All plain beta blocking agents are classfied in this group.<br />
Combination packages containing two different products (e.g. sotalol tablets and<br />
aspirin tablets in a combination package) are also classfied in this group.<br />
Labetalol, and carvedilol are classified in QC07AG - Alpha- and beta blocking<br />
agents.<br />
QC07AA<br />
Beta blocking agents, non-selective<br />
Non-selective beta blocking agents, e.g. carazolol, are classified in this group.<br />
Combined packages containing sotalol tablets and aspirin tablets are classified in<br />
QC07AA57.<br />
QC07AB<br />
Beta blocking agents, selective<br />
Selective beta blocking agents are classified in this group. The S-enantiomer and<br />
the racemate of atenolol are assigned separate 5th level codes. Preparations<br />
containing beta blocking agents should be classified according to their main<br />
indication, e.g. clenbuterol, see QR03AC14 or QR03CC13.<br />
QC07AG<br />
Alpha- and beta blocking agents<br />
55
Change language